1 |
Paintsil_2009 |
Antiviral Agents |
Paintsil, E.; Cheng, Yung-Chi |
2009 |
2009-12-31 |
PMC |
N |
PMC7149689 |
|
10.1016/b978-012373944-5.00178-4 |
itz0bdrc |
0.961778 |
|
Paintsil_2019, Vardanyan_2016, Razonable_2011, Meanwell_2003 |
2 |
Paintsil_2019 |
Antiviral Agents☆ |
Paintsil, E.; Cheng, Y.-C. |
2019 |
2019-12-31 |
PMC |
N |
PMC7150273 |
|
10.1016/b978-0-12-801238-3.02387-4 |
aqlxb6ab |
0.932427 |
|
Paintsil_2009, Vardanyan_2016, Martínez_2008 |
3 |
Llano_2018 |
Chapter Seven Defining Pharmacological Targets by Analysis of Virus–Host Protein Interactions |
Llano, Manuel; Peña-Hernandez, Mario A. |
2018 |
2018-12-31 |
PMC |
N |
PMC6322211 |
29459033.0 |
10.1016/bs.apcsb.2017.11.001 |
yzc4bosn |
0.914181 |
|
Teissier_2010 |
4 |
Wisskirchen_2014 |
New pharmacological strategies to fight enveloped viruses |
Wisskirchen, Karin; Lucifora, Julie; Michler, Thomas; Protzer, Ulrike |
2014 |
2014-09-30 |
PMC |
N |
PMC7112871 |
25108320.0 |
10.1016/j.tips.2014.06.004 |
ali14j7x |
0.914181 |
|
Martínez_2008, Schor_2018, Cagno_2018, D’Alessandro_2020 |
5 |
Wapling_2007 |
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding |
Wapling, Johanna; Srivastava, Seema; Shehu-Xhilaga, Miranda; Tachedjian, Gilda |
2007 |
2007-07-20 |
PMC |
N |
PMC3155237 |
21901072.0 |
|
oez3l9kn |
0.895601 |
|
Martínez_2008, Zhu_X_2015 |
6 |
Zimmermann_2009 |
Other Inhibitors of Viral Enzymes and Functions |
Zimmermann, H.; Hewlett, G.; Rübsamen-Waigmann, H. |
2009 |
2009-01-01 |
PMC |
N |
PMC7122372 |
19048200.0 |
10.1007/978-3-540-79086-0_6 |
jegmrrdy |
0.825284 |
Magden_2004 |
|
7 |
Shaw_2011 |
The Host Interactome of Influenza Virus Presents New Potential Targets for Antiviral Drugs |
Shaw, Megan L. |
2011 |
2011-08-08 |
None |
N |
PMC3207218 |
21823192.0 |
10.1002/rmv.703 |
c732txfd |
0.817442 |
|
Lin_K_2013, Vardanyan_2016 |
8 |
Kwong_2005 |
Viral and cellular RNA helicases as antiviral targets |
Kwong, Ann D.; Rao, B. Govinda; Jeang, Kuan-Teh |
2005 |
2005-09-23 |
PMC |
N |
PMC7097191 |
16184083.0 |
10.1038/nrd1853 |
vx7xr80t |
0.809890 |
|
Martínez_2008 |
9 |
Teissier_2010 |
Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy |
Teissier, Elodie; Penin, François; Pécheur, Eve-Isabelle |
2010 |
2010-12-30 |
COMM-USE |
N |
PMC6259279 |
21193846.0 |
10.3390/molecules16010221 |
nqw6y8ku |
0.797563 |
|
Lee_C_2019 |
10 |
Vigant_2015 |
Broad-spectrum antivirals against viral fusion |
Vigant, Frederic; Santos, Nuno C.; Lee, Benhur |
2015 |
2015-06-15 |
None |
N |
PMC4554337 |
26075364.0 |
10.1038/nrmicro3475 |
ylsal9zw |
0.784434 |
|
Cagno_2018, Müller_2009, Paintsil_2009, Debing_2013 |
11 |
Jerome_2005 |
The road to new antiviral therapies |
Jerome, Keith R. |
2005 |
2005-02-28 |
PMC |
N |
|
|
10.1016/j.cair.2004.10.002 |
t2vdzppd |
0.750468 |
|
Martínez_2008, D’Alessandro_2020, Pizzorno_2019, Kaufmann_2017 |
12 |
Zhu_J_2015 |
Broad-spectrum antiviral agents |
Zhu, Jun-Da; Meng, Wen; Wang, Xiao-Jia; Wang, Hwa-Chain R. |
2015 |
2015-05-22 |
COMM-USE |
N |
PMC4440912 |
26052325.0 |
10.3389/fmicb.2015.00517 |
nebfom1d |
0.736144 |
Li_C_2019, Dove_2004, Wisskirchen_2014 |
Martínez_2008, Gwyer_Findlay_2013, Lee_C_2019, García-Serradilla_2019 |
13 |
Magden_2004 |
Inhibitors of virus replication: recent developments and prospects |
Magden, Julia; Kääriäinen, Leevi; Ahola, Tero |
2004 |
2004-12-09 |
PMC |
N |
PMC7082807 |
15592828.0 |
10.1007/s00253-004-1783-3 |
55ceq7ze |
0.735298 |
|
Müller_2009, Paintsil_2009 |
14 |
Tai_C_2015 |
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds |
Tai, Chen-Jei; Li, Chia-Lin; Tai, Cheng-Jeng; Wang, Chien-Kai; Lin, Liang-Tzung |
2015 |
2015-10-29 |
PMC |
N |
PMC4692676 |
26555014.0 |
10.3791/53124 |
u1evs9i2 |
0.711335 |
|
Teissier_2010, Green_2008 |
15 |
Andersen_2020 |
Discovery and development of safe-in-man broad-spectrum antiviral agents |
Andersen, Petter I.; Ianevski, Aleksandr; Lysvand, Hilde; Vitkauskiene, Astra; Oksenych, Valentyn; Bjørås, Magnar; Telling, Kaidi; Lutsar, Irja; Dampis, Uga; Irie, Yasuhiko; Tenson, Tanel; Kantele, Anu; Kainov, Denis E. |
2020 |
2020-01-01 |
None |
N |
PMC7128205 |
32081774.0 |
10.1016/j.ijid.2020.02.018 |
aq76s37x |
0.705112 |
Wisskirchen_2014 |
Martínez_2008, Pizzorno_2019, Lee_C_2019 |
16 |
Müller_2009 |
Antiviral Strategies |
Müller, B.; Kräusslich, Hans-Georg |
2009 |
2009-01-01 |
PMC |
N |
PMC7120301 |
19048195.0 |
10.1007/978-3-540-79086-0_1 |
xy59hlr9 |
0.697434 |
Wisskirchen_2014 |
Lin_K_2013, Kaufmann_2017, Lee_C_2019 |
17 |
Richman_2016 |
Chapter 20 Antiviral Therapy |
Richman, Douglas D.; Nathanson, Neal |
2016 |
2016-12-31 |
PMC |
N |
PMC7149377 |
|
10.1016/b978-0-12-800964-2.00020-3 |
jwhqe5c1 |
0.696251 |
Jerome_2005 |
Martínez_2008, D’Alessandro_2020, Müller_2009 |
18 |
Gazina_2012 |
Viral targets of acylguanidines |
Gazina, Elena V.; Petrou, Steven |
2012 |
2012-09-30 |
PMC |
N |
PMC7108427 |
22580299.0 |
10.1016/j.drudis.2012.05.002 |
3jnszsrg |
0.664523 |
|
Zhu_X_2015, Lee_C_2019 |
19 |
Chew_2017 |
Peptides as Therapeutic Agents for Dengue Virus |
Chew, Miaw-Fang; Poh, Keat-Seong; Poh, Chit-Laa |
2017 |
2017-10-15 |
NONCOMM |
N |
PMC5707751 |
29200948.0 |
10.7150/ijms.21875 |
u1opdwmd |
0.640300 |
|
Lee_C_2019, Al‐Bari_2017, Jung_2019, Zhu_X_2015 |
20 |
Cagno_2018 |
Novel broad spectrum virucidal molecules against enveloped viruses |
Cagno, Valeria; Tintori, Cristina; Civra, Andrea; Cavalli, Roberta; Tiberi, Marika; Botta, Lorenzo; Brai, Annalaura; Poli, Giulio; Tapparel, Caroline; Lembo, David; Botta, Maurizio |
2018 |
2018-12-07 |
COMM-USE |
N |
PMC6285983 |
30532192.0 |
10.1371/journal.pone.0208333 |
8ak2tths |
0.623696 |
|
Lee_C_2019, Al‐Bari_2017, Xiong_2020 |
21 |
Lee_S_2012 |
Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection |
Lee, Suki Man-Yan; Yen, Hui-Ling |
2012 |
2012-12-31 |
PMC |
N |
PMC7132421 |
23022351.0 |
10.1016/j.antiviral.2012.09.013 |
kynbqk3g |
0.619259 |
|
Müller_2009, Kaufmann_2017, Lin_K_2013 |
22 |
Martínez_2008 |
Progress in the Therapeutic Applications of siRNAs Against HIV-1 |
Martínez, Miguel Angel |
2008 |
2008-10-13 |
PMC |
N |
PMC7121013 |
19301656.0 |
10.1007/978-1-60327-547-7_17 |
8jin6oru |
0.613744 |
Jerome_2005, Wisskirchen_2014 |
Zhu_X_2015, Pizzorno_2019, Wapling_2007 |
23 |
Venkataram_Prasad_2016 |
Antiviral Targets of Human Noroviruses |
Venkataram Prasad, B. V.; Shanker, Sreejesh; Muhaxhiri, Zana; Deng, Lisheng; Choi, Jae-Mun; Estes, Mary K.; Song, Yongcheng; Palzkill, Timothy; Atmar, Robert L. |
2016 |
2016-06-01 |
PMC |
N |
PMC4983487 |
27318434.0 |
10.1016/j.coviro.2016.06.002 |
05jspw9q |
0.612213 |
Wisskirchen_2014 |
|
24 |
Lin_K_2013 |
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors |
Lin, Kai; Gallay, Philippe |
2013 |
2013-07-31 |
None |
N |
PMC4332838 |
23578729.0 |
10.1016/j.antiviral.2013.03.020 |
33gvt7pe |
0.610801 |
Shaw_2011 |
Lee_C_2019 |
25 |
Wang_2019 |
Development of Small-Molecule Inhibitors Against Zika Virus Infection |
Wang, Lili; Liang, Ruiying; Gao, Yaning; Li, Yanbai; Deng, Xiaoqian; Xiang, Rong; Zhang, Yina; Ying, Tianlei; Jiang, Shibo; Yu, Fei |
2019 |
2019-12-06 |
COMM-USE |
N |
PMC6909824 |
31866959.0 |
10.3389/fmicb.2019.02725 |
lwt5nmf2 |
0.606505 |
|
D’Alessandro_2020, Martínez_2008 |
26 |
van_Boven_2008 |
Self-Interest versus Group-Interest in Antiviral Control |
van Boven, Michiel; Klinkenberg, Don; Pen, Ido; Weissing, Franz J.; Heesterbeek, Hans |
2008 |
2008-02-13 |
COMM-USE |
N |
PMC2592701 |
19050769.0 |
10.1371/journal.pone.0001558 |
sasijnks |
0.602006 |
|
Pizzorno_2019, Paintsil_2009, Dunning_2014 |
27 |
Lusvarghi_2016 |
Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential |
Lusvarghi, Sabrina; Bewley, Carole A. |
2016 |
2016-10-24 |
COMM-USE |
N |
PMC5086628 |
27783038.0 |
10.3390/v8100296 |
ydclax3n |
0.601247 |
|
Lee_C_2019 |
28 |
Takizawa_2017 |
Current landscape and future prospects of antiviral drugs derived from microbial products |
Takizawa, Naoki; Yamasaki, Manabu |
2017 |
2017-10-11 |
PMC |
N |
PMC7091927 |
29018267.0 |
10.1038/ja.2017.115 |
4whzcmqv |
0.595942 |
|
Martínez_2008, Pizzorno_2019, D’Alessandro_2020 |
29 |
Koff_1985 |
The potential use of liposome-mediated antiviral therapy |
Koff, Wayne C.; Fidler, Isaiah J. |
1985 |
1985-06-30 |
PMC |
N |
|
3896138.0 |
10.1016/0166-3542(85)90050-6 |
vazc4c5d |
0.594405 |
|
|
30 |
Vardanyan_2016 |
Chapter 34 Antiviral Drugs |
Vardanyan, Ruben; Hruby, Victor |
2016 |
2016-12-31 |
PMC |
N |
PMC7149618 |
|
10.1016/b978-0-12-411492-0.00034-1 |
ng6h4l3m |
0.592767 |
Yu_F_2018, Magden_2004, Sperber_1987, Wu_X_2017 |
Paintsil_2009, Chang_2019, Razonable_2011 |
31 |
Sousa_2016 |
Antiviral Host Defence Peptides |
Sousa, Filipa Henderson; Casanova, Victor; Stevens, Craig; Barlow, Peter G. |
2016 |
2016-03-25 |
PMC |
N |
PMC7123656 |
|
10.1007/978-3-319-32949-9_3 |
9pokc6km |
0.588638 |
|
Gwyer_Findlay_2013, Kaufmann_2017, Schor_2018 |
32 |
Debing_2013 |
Intervention strategies for emerging viruses: use of antivirals |
Debing, Yannick; Jochmans, Dirk; Neyts, Johan |
2013 |
2013-04-30 |
PMC |
N |
PMC7102692 |
23562753.0 |
10.1016/j.coviro.2013.03.001 |
1vxl2468 |
0.586986 |
|
D’Alessandro_2020, Martínez_2008, Vardanyan_2016 |
33 |
Tan_C_2014 |
Recent developments in antiviral agents against enterovirus 71 infection |
Tan, Chee Wah; Lai, Jeffrey Kam Fatt; Sam, I-Ching; Chan, Yoke Fun |
2014 |
2014-02-12 |
COMM-USE |
N |
PMC3924904 |
24521134.0 |
10.1186/1423-0127-21-14 |
2tji14il |
0.583345 |
|
Kuo_R_2013 |
34 |
Serban_2020 |
Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections |
Serban, Georgeta |
2020 |
2020-02-19 |
COMM-USE |
N |
PMC7070519 |
32093125.0 |
10.3390/molecules25040942 |
5uuhmftx |
0.563261 |
Li_C_2019, Beigel_2010, Fernández‐Oliva_2019 |
Zhu_X_2015, Lee_C_2019 |
35 |
Shih_2004 |
Selective human enterovirus and rhinovirus inhibitors: An overview of capsid‐binding and protease‐inhibiting molecules |
Shih, Shin‐Ru; Chen, Shu‐Jen; Hakimelahi, Gholam Hossein; Liu, Hsing‐Jang; Tseng, Chen‐Tso; Shia, Kak‐Shan |
2004 |
2004-04-07 |
PMC |
N |
PMC7168432 |
15170592.0 |
10.1002/med.10067 |
bkkkltdy |
0.559749 |
|
|
36 |
Jalily_2020 |
Put a cork in it: Plugging the M2 viral ion channel to sink influenza |
Jalily, Pouria H.; Duncan, Maggie C.; Fedida, David; Wang, Jun; Tietjen, Ian |
2020 |
2020-03-27 |
PMC |
N |
|
|
10.1016/j.antiviral.2020.104780 |
6p6826o6 |
0.557648 |
|
Balgi_2013 |
37 |
Shi_P_2009 |
Novel Therapeutics Against West Nile Virus |
Shi, Pei-Yong |
2009 |
2009-01-01 |
PMC |
N |
PMC7122128 |
|
10.1007/978-0-387-79840-0_21 |
x6ex0yyx |
0.552585 |
Martínez_2008, Dove_2004 |
Lee_C_2019, Martínez_2008 |
38 |
Jung_2019 |
Neutralization of Acidic Intracellular Vesicles by Niclosamide Inhibits Multiple Steps of the Dengue Virus Life Cycle In Vitro |
Jung, Eunhye; Nam, Sangwoo; Oh, Hyeryeon; Jun, Sangmi; Ro, Hyun-Joo; Kim, Baek; Kim, Meehyein; Go, Yun Young |
2019 |
2019-06-18 |
COMM-USE |
N |
PMC6582152 |
31213630.0 |
10.1038/s41598-019-45095-1 |
wmfwl2bh |
0.549546 |
|
Hsieh_2010, Al‐Bari_2017 |
39 |
Pawlotsky_2014 |
What are the pros and cons of the use of host-targeted agents against hepatitis C? |
Pawlotsky, Jean-Michel |
2014 |
2014-05-31 |
PMC |
N |
|
24583032.0 |
10.1016/j.antiviral.2014.02.008 |
px1xaszl |
0.543890 |
Shaw_2011 |
|
40 |
Schor_2018 |
Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs |
Schor, Stanford; Einav, Shirit |
2018 |
2018-01-03 |
PMC |
N |
PMC5807128 |
29298032.0 |
10.1021/acsinfecdis.7b00268 |
b4u63jgo |
0.539695 |
Li_C_2019 |
Zilbermintz_2015, Lee_C_2019 |
41 |
Mercorelli_2011 |
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives |
Mercorelli, Beatrice; Lembo, David; Palù, Giorgio; Loregian, Arianna |
2011 |
2011-09-30 |
PMC |
N |
PMC7112563 |
21570424.0 |
10.1016/j.pharmthera.2011.04.007 |
a9yaj8mw |
0.537540 |
Jerome_2005 |
Wu_H_2016, Zhu_X_2015 |
42 |
Vere_Hodge_2011 |
13 General Mechanisms of Antiviral Resistance |
Vere Hodge, Anthony; Field, Hugh J. |
2011 |
2011-12-31 |
PMC |
N |
PMC7150307 |
|
10.1016/b978-0-12-384890-1.00013-3 |
p6c57zzm |
0.535654 |
Shaw_2011 |
Lin_K_2013, Müller_2009, Lee_C_2019 |
43 |
Ianevski_2018 |
Novel activities of safe-in-human broad-spectrum antiviral agents |
Ianevski, Aleksandr; Zusinaite, Eva; Kuivanen, Suvi; Strand, Mårten; Lysvand, Hilde; Teppor, Mona; Kakkola, Laura; Paavilainen, Henrik; Laajala, Mira; Kallio-Kokko, Hannimari; Valkonen, Miia; Kantele, Anu; Telling, Kaidi; Lutsar, Irja; Letjuka, Pille; Metelitsa, Natalja; Oksenych, Valentyn; Bjørås, Magnar; Nordbø, Svein Arne; Dumpis, Uga; Vitkauskiene, Astra; Öhrmalm, Christina; Bondeson, Kåre; Bergqvist, Anders; Aittokallio, Tero; Cox, Rebecca J.; Evander, Magnus; Hukkanen, Veijo; Marjomaki, Varpu; Julkunen, Ilkka; Vapalahti, Olli; Tenson, Tanel; Merits, Andres; Kainov, Denis |
2018 |
2018-06-30 |
PMC |
N |
PMC7113852 |
29698664.0 |
10.1016/j.antiviral.2018.04.016 |
gcfx1095 |
0.531945 |
|
Lee_C_2019, Blaising_2014, Zhu_X_2015, Xiong_2020 |
44 |
Villa_2017 |
Antivirals against animal viruses |
Villa, T.G.; Feijoo-Siota, L.; Rama, J.L.R.; Ageitos, J.M. |
2017 |
2017-06-01 |
PMC |
N |
PMC7092833 |
27697545.0 |
10.1016/j.bcp.2016.09.029 |
gilar94m |
0.530840 |
|
Lee_C_2019, Müller_2009, da_Mata_2017 |
45 |
Lee_C_2019 |
Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application |
Lee, Choongho |
2019 |
2019-10-06 |
COMM-USE |
N |
PMC6835697 |
31590428.0 |
10.3390/md17100567 |
gxbrgy6g |
0.525745 |
|
Lusvarghi_2016 |
46 |
Bule_2019 |
Antivirals: Past, Present and Future |
Bule, Mohammed; Khan, Fazlullah; Niaz, Kamal |
2019 |
2019-06-06 |
PMC |
N |
PMC7120554 |
|
10.1007/978-981-13-9073-9_22 |
6mw8okmt |
0.525413 |
Wisskirchen_2014, Li_C_2019, Pizzorno_2019 |
D’Alessandro_2020, Pizzorno_2019, Martínez_2008, Gwyer_Findlay_2013 |
47 |
Saiz_2018 |
Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus |
Saiz, Juan-Carlos; de Oya, Nereida Jiménez; Blázquez, Ana-Belén; Escribano-Romero, Estela; Martín-Acebes, Miguel A. |
2018 |
2018-08-24 |
COMM-USE |
N |
PMC6163279 |
30149598.0 |
10.3390/v10090453 |
gmw8gl2r |
0.525413 |
|
Lee_C_2019, Wu_H_2016 |
48 |
Toots_2020 |
Next-generation direct-acting influenza therapeutics |
Toots, Mart; Plemper, Richard K. |
2020 |
2020-02-04 |
PMC |
N |
|
|
10.1016/j.trsl.2020.01.005 |
n1ugd7cb |
0.508026 |
|
|
49 |
da_Mata_2017 |
Antiviral activity of animal venom peptides and related compounds |
da Mata, Élida Cleyse Gomes; Mourão, Caroline Barbosa Farias; Rangel, Marisa; Schwartz, Elisabeth Ferroni |
2017 |
2017-01-06 |
COMM-USE |
N |
PMC5217322 |
28074089.0 |
10.1186/s40409-016-0089-0 |
lknyehsa |
0.499866 |
|
Lee_C_2019, Chang_2019 |
50 |
Bulanova_2017 |
Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins |
Bulanova, Daria; Ianevski, Aleksandr; Bugai, Andrii; Akimov, Yevhen; Kuivanen, Suvi; Paavilainen, Henrik; Kakkola, Laura; Nandania, Jatin; Turunen, Laura; Ohman, Tiina; Ala-Hongisto, Hanna; Pesonen, Hanna M.; Kuisma, Marika S.; Honkimaa, Anni; Walton, Emma L.; Oksenych, Valentyn; Lorey, Martina B.; Guschin, Dmitry; Shim, Jungmin; Kim, Jinhee; Than, Thoa T.; Chang, So Young; Hukkanen, Veijo; Kulesskiy, Evgeny; Marjomaki, Varpu S.; Julkunen, Ilkka; Nyman, Tuula A.; Matikainen, Sampsa; Saarela, Jani S.; Sane, Famara; Hober, Didier; Gabriel, Gülsah; De Brabander, Jef K.; Martikainen, Miika; Windisch, Marc P.; Min, Ji-Young; Bruzzone, Roberto; Aittokallio, Tero; Vähä-Koskela, Markus; Vapalahti, Olli; Pulk, Arto; Velagapudi, Vidya; Kainov, Denis E. |
2017 |
2017-09-25 |
COMM-USE |
N |
PMC5691623 |
28946654.0 |
10.3390/v9100271 |
vds27ejv |
0.499855 |
|
|
51 |
Li_C_2017 |
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice |
Li, Chunfeng; Zhu, Xingliang; Ji, Xue; Quanquin, Natalie; Deng, Yong-Qiang; Tian, Min; Aliyari, Roghiyh; Zuo, Xiangyang; Yuan, Ling; Afridi, Shabbir Khan; Li, Xiao-Feng; Jung, Jae U.; Nielsen-Saines, Karin; Qin, Frank Xiao-Feng; Qin, Cheng-Feng; Xu, Zhiheng; Cheng, Genhong |
2017 |
2017-09-28 |
None |
N |
PMC5652284 |
29033372.0 |
10.1016/j.ebiom.2017.09.034 |
fzgwfb27 |
0.499849 |
|
|
52 |
Gwyer_Findlay_2013 |
Cationic Host Defence Peptides: Potential as Antiviral Therapeutics |
Gwyer Findlay, Emily; Currie, Silke M.; Davidson, Donald J. |
2013 |
2013-05-07 |
PMC |
N |
PMC3775153 |
23649937.0 |
10.1007/s40259-013-0039-0 |
c6cjxq07 |
0.499843 |
Wisskirchen_2014 |
Lee_C_2019, Ahmed_2019, Zhu_X_2015 |
53 |
Fernández‐Oliva_2019 |
Targeting host lipid flows: Exploring new antiviral and antibiotic strategies |
Fernández‐Oliva, Alberto; Ortega‐González, Paula; Risco, Cristina |
2019 |
2019-01-17 |
PMC |
N |
PMC7162424 |
30585688.0 |
10.1111/cmi.12996 |
pra0398r |
0.499819 |
Wisskirchen_2014 |
|
54 |
Bekerman_2015 |
Combating emerging viral threats |
Bekerman, Elena; Einav, Shirit |
2015 |
2015-04-16 |
PMC |
N |
PMC4419706 |
25883340.0 |
10.1126/science.aaa3778 |
pxahhwr9 |
0.499809 |
Dove_2004, Li_C_2019, Wisskirchen_2014 |
Schor_2018, García-Serradilla_2019, Gwyer_Findlay_2013, Zilbermintz_2015 |
55 |
Le_Grice_2015 |
Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder |
Le Grice, Stuart F. J. |
2015 |
2015-03-04 |
PMC |
N |
PMC7120518 |
25735922.0 |
10.1007/82_2015_434 |
ywslqh3a |
0.486925 |
|
|
56 |
Milovanovic_2017 |
Chapter 14 Nanoparticles in Antiviral Therapy |
Milovanovic, Marija; Arsenijevic, Aleksandar; Milovanovic, Jelena; Kanjevac, Tatjana; Arsenijevic, Nebojsa |
2017 |
2017-12-31 |
PMC |
N |
|
|
10.1016/b978-0-323-52733-0.00014-8 |
eld5svt2 |
0.484116 |
Sousa_2016 |
|
57 |
Pizzorno_2019 |
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy |
Pizzorno, Andrés; Padey, Blandine; Terrier, Olivier; Rosa-Calatrava, Manuel |
2019 |
2019-03-19 |
COMM-USE |
N |
PMC6434107 |
30941148.0 |
10.3389/fimmu.2019.00531 |
mqvm4q22 |
0.481932 |
Dove_2004 |
Martínez_2008, Mercorelli_2018, Schor_2018, D’Alessandro_2020 |
58 |
Leyssen_2008 |
Molecular strategies to inhibit the replication of RNA viruses |
Leyssen, Pieter; De Clercq, Erik; Neyts, Johan |
2008 |
2008-04-30 |
PMC |
N |
PMC7114363 |
18313769.0 |
10.1016/j.antiviral.2008.01.004 |
ir8ibr87 |
0.475563 |
|
Vardanyan_2016 |
59 |
Green_2008 |
Cell-based Assays to Identify Inhibitors of Viral Disease |
Green, Neil; Ott, Robert D.; Isaacs, Richard J.; Fang, Hong |
2008 |
2008-05-22 |
PMC |
N |
PMC2741327 |
19750206.0 |
10.1517/17460441.3.6.671 |
6tx2ze0c |
0.473758 |
|
|
60 |
de_la_Torre_2008 |
Reverse genetics approaches to combat pathogenic arenaviruses |
de la Torre, Juan C. |
2008 |
2008-12-31 |
None |
N |
PMC2628465 |
18782590.0 |
10.1016/j.antiviral.2008.08.002 |
wvtqbguq |
0.471891 |
|
|
61 |
Blaising_2014 |
Arbidol as a broad-spectrum antiviral: An update |
Blaising, Julie; Polyak, Stephen J.; Pécheur, Eve-Isabelle |
2014 |
2014-07-31 |
PMC |
N |
PMC7113885 |
24769245.0 |
10.1016/j.antiviral.2014.04.006 |
d9borky8 |
0.466147 |
Jerome_2005 |
Lee_C_2019 |
62 |
Hermann_2016 |
Small molecules targeting viral RNA |
Hermann, Thomas |
2016 |
2016-06-16 |
PMC |
N |
PMC7169885 |
27307213.0 |
10.1002/wrna.1373 |
hfwd6t2k |
0.464524 |
|
|
63 |
Fechner_2011 |
Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections |
Fechner, Henry; Pinkert, Sandra; Geisler, Anja; Poller, Wolfgang; Kurreck, Jens |
2011 |
2011-10-11 |
COMM-USE |
N |
PMC6264230 |
21989310.0 |
10.3390/molecules16108475 |
99q1bhba |
0.458936 |
|
|
64 |
Nath_2013 |
Novel approaches and challenges to treatment of CNS viral infections |
Nath, Avindra; Tyler, Kenneth L. |
2013 |
2013-09-01 |
None |
N |
PMC4052367 |
23913580.0 |
10.1002/ana.23988 |
h7g5ecc0 |
0.457259 |
Wisskirchen_2014, Jerome_2005 |
Kaufmann_2017, Martínez_2008, Lin_K_2013 |
65 |
Byler_2016 |
In-silico screening for anti-Zika virus phytochemicals |
Byler, Kendall G.; Ogungbe, Ifedayo Victor; Setzer, William N. |
2016 |
2016-09-30 |
PMC |
N |
|
27588363.0 |
10.1016/j.jmgm.2016.08.011 |
grszsrp6 |
0.453194 |
|
|
66 |
Hodinka_1997 |
WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE |
Hodinka, Richard L. |
1997 |
1997-12-01 |
PMC |
N |
|
9421709.0 |
10.1016/s0891-5520(05)70399-8 |
6324190r |
0.452116 |
Jerome_2005 |
|
67 |
Powell_2017 |
5.20 Antiviral Drugs for Acute Infections |
Powell, K.L.; Thomas, E.; Cockerill, G.S. |
2017 |
2017-12-31 |
PMC |
N |
PMC7149606 |
|
10.1016/b978-0-12-409547-2.12408-4 |
50hivtvi |
0.452011 |
Jerome_2005 |
D’Alessandro_2020, Martínez_2008, Mercorelli_2018 |
68 |
Rut_W_2020 |
Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design |
Wioletta Rut; Katarzyna Groborz; Linlin Zhang; Xinyuanyuan Sun; Mikolaj Zmudzinski; Rolf Hilgenfeld; Marcin Drag |
2020 |
2020-03-08 |
BioRxiv |
Y |
|
|
10.1101/2020.03.07.981928 |
e8qubwha |
0.451525 |
Pizzorno_2019, Shaw_2011 |
Adhikari_2017, Zhu_X_2015 |
69 |
Zhu_Z_2019 |
Prediction of antiviral drugs against African Swine Fever Viruses based on protein-protein interaction analysis |
Zhaozhong Zhu; Yunshi Fan; Zena Cai; Zheng Zhang; Congyu Lu; Taijiao Jiang; Gaihua Zhang; Yousong Peng |
2019 |
2019-04-05 |
BioRxiv |
N |
|
|
10.1101/599043 |
w2i6qe0r |
0.450261 |
Shaw_2011 |
|
70 |
Lin_L_2014 |
Antiviral Natural Products and Herbal Medicines |
Lin, Liang-Tzung; Hsu, Wen-Chan; Lin, Chun-Ching |
2014 |
2014-03-31 |
PMC |
N |
PMC4032839 |
24872930.0 |
10.4103/2225-4110.124335 |
ut71y7sd |
0.449661 |
Dove_2004 |
Chattopadhyay_2015, Mukherjee_2019, D’Alessandro_2020 |
71 |
Christopher_2011 |
Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections |
Christopher, ME; Wong, JP |
2011 |
2011-10-23 |
COMM-USE |
N |
PMC3552307 |
|
10.2174/187152111800194434 |
of9t5i10 |
0.445838 |
|
|
72 |
Savarino_2003 |
Effects of chloroquine on viral infections: an old drug against today's diseases |
Savarino, Adrea; Boelaert, John R; Cassone, Antonio; Majori, Giancario; Cauda, Roberto |
2003 |
2003-11-30 |
PMC |
N |
PMC7128816 |
14592603.0 |
10.1016/s1473-3099(03)00806-5 |
lgnhlxgd |
0.443540 |
|
Wu_H_2016 |
73 |
Gordon_2020 |
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing |
David E. Gordon; Gwendolyn M. Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Matthew J O'Meara; Jeffrey Z. Guo; Danielle L. Swaney; Tia A. Tummino; Ruth Huttenhain; Robyn Kaake; Alicia L. Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J. Polacco; Hannes Braberg; Jacqueline M. Fabius; Manon Eckhardt; Margaret Soucheray; Melanie Brewer; Merve Cakir; Michael J. McGregor; Qiongyu Li; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ilsa T. Kirby; James E. Melnyk; John S Chorba; Kevin Lou; Shizhong A. Dai; Wenqi Shen; Ying Shi; Ziyang Zhang; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Christopher J.P. Mathy; Tina Perica; Kala B. Pilla; Sai J. Ganesan; Daniel J. Saltzberg; Rakesh Ramachandran; Xi Liu; Sara B. Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Yizhu Lin; Stephanie A. Wankowicz; Markus Bohn; Phillip P. Sharp; Raphael Trenker; Janet M. Young; Devin A. Cavero; Joseph Hiatt; Theo Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Ferdinand Roesch; Thomas Vallet; Björn Meyer; Kris M. White; Lisa Miorin; Oren S. Rosenberg; Kliment A. Verba; David Agard; Melanie Ott; Michael Emerman; Davide Ruggero; Adolfo Garcí-Sastre; Natalia Jura; Mark von Zastrow; Jack Taunton; Olivier Schwartz; Marco Vignuzzi; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S. Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen Floor; James S. Fraser; John Gross; Andrej Sali; Tanja Kortemme; Pedro Beltrao; Kevan Shokat; Brian K. Shoichet; Nevan J. Krogan |
2020 |
2020-03-22 |
BioRxiv |
Y |
|
|
10.1101/2020.03.22.002386 |
38d6gb7o |
0.442886 |
|
|
74 |
Rumlová_2018 |
In vitro methods for testing antiviral drugs |
Rumlová, Michaela; Ruml, Tomáš |
2018 |
2018-06-30 |
PMC |
N |
PMC7127693 |
29292156.0 |
10.1016/j.biotechadv.2017.12.016 |
884x48on |
0.437137 |
Dove_2004 |
Martínez_2008, D’Alessandro_2020, García-Serradilla_2019, Pizzorno_2019 |
75 |
Ju_J_2020 |
Nucleotide Analogues as Inhibitors of Viral Polymerases |
Jingyue Ju; Shiv Kumar; Xiaoxu Li; Steffen Jockusch; James J. Russo |
2020 |
2020-01-31 |
BioRxiv |
Y |
|
|
10.1101/2020.01.30.927574 |
dpcpg5c1 |
0.437137 |
|
Xiong_2020 |
76 |
Deval_2014 |
Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus |
Deval, Jerome; Symons, Julian A; Beigelman, Leo |
2014 |
2014-12-31 |
PMC |
N |
PMC7102778 |
25194816.0 |
10.1016/j.coviro.2014.08.004 |
qovrstak |
0.436566 |
|
Vardanyan_2016 |
77 |
Mukherjee_2019 |
Chapter 16 Antiviral Evaluation of Herbal Drugs |
Mukherjee, Pulok K. |
2019 |
2019-12-31 |
PMC |
N |
PMC7149824 |
|
10.1016/b978-0-12-813374-3.00016-8 |
12rbbe8c |
0.430560 |
Jerome_2005 |
Lee_C_2019, D’Alessandro_2020, Bekut_2018 |
78 |
Diosa-Toro_2013 |
Chapter Four Arthropod-Borne Flaviviruses and RNA Interference Seeking New Approaches for Antiviral Therapy |
Diosa-Toro, Mayra; Urcuqui-Inchima, Silvio; Smit, Jolanda M. |
2013 |
2013-12-31 |
PMC |
N |
PMC7149629 |
23439025.0 |
10.1016/b978-0-12-408116-1.00004-5 |
eyukbot7 |
0.429189 |
|
Lee_C_2019 |
79 |
Lu_Y_2019 |
Computational identification of self-inhibitory peptides from white spot syndrome virus envelope protein VP28 |
Lu, Yongzhong; Qiu, Qian; Li, Chen; Cheng, Linyue; Liu, Jie |
2019 |
2019-07-31 |
PMC |
N |
PMC7104047 |
|
10.1016/j.aqrep.2019.100195 |
x2kp0wpp |
0.427467 |
Shaw_2011 |
Lee_C_2019, Lusvarghi_2016 |
80 |
Yu_F_2018 |
Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains |
Yu, Fei; Li, Wen; Wang, Lili; Dai, Yu; Lu, Xin; Wang, Qian; Xie, Lan; Jiang, Shibo |
2018 |
2018-07-02 |
COMM-USE |
N |
PMC6099689 |
30004408.0 |
10.3390/molecules23071599 |
uyzp7ele |
0.427130 |
Vardanyan_2016, Sperber_1987 |
Zhu_X_2015 |
81 |
Bauer_2017 |
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections |
Bauer, Lisa; Lyoo, Heyrhyoung; van der Schaar, Hilde M; Strating, Jeroen RPM; van Kuppeveld, Frank JM |
2017 |
2017-06-30 |
PMC |
N |
|
28411509.0 |
10.1016/j.coviro.2017.03.009 |
ij34t1ae |
0.424086 |
Wisskirchen_2014, Jerome_2005 |
|
82 |
Jiang_2010 |
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines |
Jiang, Shibo; Li, Runming; Du, Lanying; Liu, Shuwen |
2010 |
2010-04-01 |
PMC |
N |
PMC4728157 |
21203946.0 |
10.1007/s13238-010-0054-6 |
r46d5kdu |
0.421012 |
|
|
83 |
Cao_R_2017 |
Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika |
Cao, Rui-Yuan; Xu, Yong-fen; Zhang, Tian-Hong; Yang, Jing-Jing; Yuan, Ye; Hao, Pei; Shi, Yi; Zhong, Jin; Zhong, Wu |
2017 |
2017-02-03 |
NONCOMM |
N |
PMC5414027 |
28480282.0 |
10.1093/ofid/ofx009 |
sbf9qi6g |
0.421012 |
Jerome_2005 |
Wu_H_2016 |
84 |
Bernini_2006 |
Tertiary structure prediction of SARS coronavirus helicase |
Bernini, Andrea; Spiga, Ottavia; Venditti, Vincenzo; Prischi, Filippo; Bracci, Luisa; Huang, Jiandong; Tanner, Julian A.; Niccolai, Neri |
2006 |
2006-05-19 |
PMC |
N |
PMC7092897 |
16579970.0 |
10.1016/j.bbrc.2006.03.069 |
ex3vep1z |
0.414740 |
|
|
85 |
García-Serradilla_2019 |
Drug repurposing for new, efficient, broad spectrum antivirals |
García-Serradilla, Moisés; Risco, Cristina; Pacheco, Beatriz |
2019 |
2019-04-15 |
PMC |
N |
PMC7114681 |
30794895.0 |
10.1016/j.virusres.2019.02.011 |
75zgljet |
0.414073 |
Dove_2004 |
Pizzorno_2019, Schor_2018, Mercorelli_2018, Martínez_2008 |
86 |
Novella_1995 |
Rapid viral quasispecies evolution: implications for vaccine and drug strategies |
Novella, Isabel S.; Domingo, Esteban; Holland, John J. |
1995 |
1995-08-31 |
PMC |
N |
|
17607887.0 |
10.1016/s1357-4310(95)91551-6 |
15zfvsur |
0.413412 |
|
|
87 |
Yang_2005 |
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases |
Yang, Haitao; Xie, Weiqing; Xue, Xiaoyu; Yang, Kailin; Ma, Jing; Liang, Wenxue; Zhao, Qi; Zhou, Zhe; Pei, Duanqing; Ziebuhr, John; Hilgenfeld, Rolf; Yuen, Kwok Yung; Wong, Luet; Gao, Guangxia; Chen, Saijuan; Chen, Zhu; Ma, Dawei; Bartlam, Mark; Rao, Zihe |
2005 |
2005-09-06 |
None |
N |
PMC1197287 |
16128623.0 |
10.1371/journal.pbio.0030324 |
2vlvz5o9 |
0.412982 |
|
Lee_C_2019 |
88 |
GASPARINI_2014 |
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza Part II: Future compounds against influenza virus |
GASPARINI, R.; AMICIZIA, D.; LAI, P.L.; BRAGAZZI, N.L.; PANATTO, D. |
2014 |
2014-12-23 |
NONCOMM |
N |
PMC4718316 |
26137785.0 |
|
oozejbs9 |
0.409179 |
|
De_Clercq_2007, Pizzorno_2019, Zhu_X_2015, Wu_X_2017 |
89 |
Zhou_2011 |
Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay |
Zhou, Yanchen; Agudelo, Juliet; Lu, Kai; Goetz, David H.; Hansell, Elizabeth; Chen, Yen Ting; Roush, William R.; McKerrow, James; Craik, Charles S.; Amberg, Sean M.; Simmons, Graham |
2011 |
2011-11-30 |
None |
N |
PMC3205982 |
21820471.0 |
10.1016/j.antiviral.2011.07.016 |
mtf7k4t8 |
0.407002 |
|
Yamamoto_2004 |
90 |
Cojocaru_2020 |
Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers |
Cojocaru, Florina-Daniela; Botezat, Doru; Gardikiotis, Ioannis; Uritu, Cristina-Mariana; Dodi, Gianina; Trandafir, Laura; Rezus, Ciprian; Rezus, Elena; Tamba, Bogdan-Ionel; Mihai, Cosmin-Teodor |
2020 |
2020-02-18 |
COMM-USE |
N |
PMC7076512 |
32085535.0 |
10.3390/pharmaceutics12020171 |
guiy89x8 |
0.406244 |
Dove_2004, Li_C_2019 |
Lin_Y_2015 |
91 |
Skalickova_2015 |
Perspective of Use of Antiviral Peptides against Influenza Virus |
Skalickova, Sylvie; Heger, Zbynek; Krejcova, Ludmila; Pekarik, Vladimir; Bastl, Karel; Janda, Jozef; Kostolansky, Frantisek; Vareckova, Eva; Zitka, Ondrej; Adam, Vojtech; Kizek, Rene |
2015 |
2015-10-20 |
COMM-USE |
N |
PMC4632391 |
26492266.0 |
10.3390/v7102883 |
9s0ypnne |
0.402088 |
|
Hillaire_2011, Gwyer_Findlay_2013 |
92 |
Salata_2017 |
Antiviral activity of cationic amphiphilic drugs |
Salata, Cristiano; Calistri, Arianna; Parolin, Cristina; Baritussio, Aldo; Palù, Giorgio |
2017 |
2017-03-20 |
PMC |
N |
PMC7103695 |
28286997.0 |
10.1080/14787210.2017.1305888 |
05fiqpeg |
0.396881 |
Beigel_2010, Wisskirchen_2014, Pizzorno_2019 |
Lee_C_2019, Al‐Bari_2017, Gwyer_Findlay_2013 |
93 |
Bekut_2018 |
Potential of selected Lamiaceae plants in anti(retro)viral therapy |
Bekut, Maja; Brkić, Snežana; Kladar, Nebojša; Dragović, Gordana; Gavarić, Neda; Božin, Biljana |
2018 |
2018-07-31 |
PMC |
N |
PMC7129285 |
29258916.0 |
10.1016/j.phrs.2017.12.016 |
e4kd2jgy |
0.395729 |
|
Lee_C_2019 |
94 |
Bossart_2007 |
Targeted Strategies for Henipavirus Therapeutics |
Bossart, Katharine N; Bingham, John; Middleton, Deborah |
2007 |
2007-09-28 |
COMM-USE |
N |
PMC2675550 |
19440455.0 |
10.2174/1874357900701010014 |
9ohavixk |
0.386230 |
Wisskirchen_2014 |
Hsieh_2010, Wu_H_2016 |
95 |
Zhao_2016 |
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses |
Zhao, Hanjun; Zhou, Jie; Zhang, Ke; Chu, Hin; Liu, Dabin; Poon, Vincent Kwok-Man; Chan, Chris Chung-Sing; Leung, Ho-Chuen; Fai, Ng; Lin, Yong-Ping; Zhang, Anna Jin-Xia; Jin, Dong-Yan; Yuen, Kwok-Yung; Zheng, Bo-Jian |
2016 |
2016-02-25 |
COMM-USE |
N |
PMC4766503 |
26911565.0 |
10.1038/srep22008 |
4tx1pdxw |
0.382555 |
|
Lee_C_2019, Zhu_X_2015, Xiong_2020 |
96 |
Kaur_2013 |
Chikungunya virus: an update on antiviral development and challenges |
Kaur, Parveen; Chu, Justin Jang Hann |
2013 |
2013-10-31 |
PMC |
N |
PMC7108317 |
23684571.0 |
10.1016/j.drudis.2013.05.002 |
tcy7jrth |
0.380791 |
|
Wu_H_2016, Lee_C_2019 |
97 |
Gao_Y_2019 |
Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors |
Gao, Yaning; Tai, Wanbo; Wang, Ning; Li, Xiang; Jiang, Shibo; Debnath, Asim K.; Du, Lanying; Chen, Shizhong |
2019 |
2019-11-02 |
COMM-USE |
N |
PMC6893700 |
31684080.0 |
10.3390/v11111019 |
qtwcbn7m |
0.380272 |
|
Bekut_2018 |
98 |
Warren_2014 |
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 |
Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina |
2014 |
2014-03-02 |
None |
N |
PMC7095208 |
24590073.0 |
10.1038/nature13027 |
uwdzic4k |
0.380019 |
|
|
99 |
Zilbermintz_2015 |
Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting |
Zilbermintz, Leeor; Leonardi, William; Jeong, Sun-Young; Sjodt, Megan; McComb, Ryan; Ho, Chi-Lee C.; Retterer, Cary; Gharaibeh, Dima; Zamani, Rouzbeh; Soloveva, Veronica; Bavari, Sina; Levitin, Anastasia; West, Joel; Bradley, Kenneth A.; Clubb, Robert T.; Cohen, Stanley N.; Gupta, Vivek; Martchenko, Mikhail |
2015 |
2015-08-27 |
None |
N |
PMC4550849 |
26310922.0 |
10.1038/srep13476 |
7t4mli1z |
0.379452 |
|
Schor_2018, Lee_C_2019 |
100 |
Wathen_2012 |
Antivirals in seasonal and pandemic influenza—future perspectives |
Wathen, Michael W.; Barro, Mario; Bright, Rick A. |
2012 |
2012-12-28 |
PMC |
N |
PMC5978628 |
23279900.0 |
10.1111/irv.12049 |
ljosmial |
0.378616 |
|
Dunning_2014 |
101 |
Keating_2011 |
Phosphorylation events during viral infections provide potential therapeutic targets |
Keating, Julie A.; Striker, Rob |
2011 |
2011-11-24 |
None |
N |
PMC3334462 |
22113983.0 |
10.1002/rmv.722 |
wz4nsbtc |
0.378413 |
|
|
102 |
Rollinger_2010 |
The human rhinovirus: human‐pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery |
Rollinger, Judith M.; Schmidtke, Michaela |
2010 |
2010-12-13 |
PMC |
N |
PMC7168442 |
19714577.0 |
10.1002/med.20176 |
ycc3csyh |
0.377984 |
|
|
103 |
Deval_2017 |
Structure(s), function(s), and inhibition of the RNA-dependent RNA polymerase of noroviruses |
Deval, Jerome; Jin, Zhinan; Chuang, Ying-Chih; Kao, C. Cheng |
2017 |
2017-04-15 |
PMC |
N |
PMC7114559 |
28041960.0 |
10.1016/j.virusres.2016.12.018 |
v28wbrqp |
0.377746 |
|
|
104 |
Salazar_2017 |
Antibody therapies for the prevention and treatment of viral infections |
Salazar, Georgina; Zhang, Ningyan; Fu, Tong-Ming; An, Zhiqiang |
2017 |
2017-07-10 |
COMM-USE |
N |
PMC5627241 |
29263875.0 |
10.1038/s41541-017-0019-3 |
0gfxy9z6 |
0.370905 |
Wisskirchen_2014 |
Kaufmann_2017, Martínez_2008, Flego_2013 |
105 |
Ramana_2014 |
Targeting strategies for delivery of anti-HIV drugs |
Ramana, Lakshmi Narashimhan; Anand, Appakkudal R.; Sethuraman, Swaminathan; Krishnan, Uma Maheswari |
2014 |
2014-10-28 |
PMC |
N |
PMC7114626 |
25119469.0 |
10.1016/j.jconrel.2014.08.003 |
hbv49e01 |
0.370511 |
Martínez_2008, Wisskirchen_2014, Pizzorno_2019 |
Martínez_2008, Zhu_X_2015, Kaufmann_2017 |
106 |
Hellen_1992 |
Viral proteases as targets for chemotherapeutic intervention |
Hellen, Christopher U.T.; Wimmer, Eckard |
1992 |
1992-12-31 |
PMC |
N |
|
1369416.0 |
10.1016/0958-1669(92)90010-g |
dt9m596i |
0.369716 |
|
|
107 |
D’Alessandro_2020 |
The Use of Antimalarial Drugs against Viral Infection |
D’Alessandro, Sarah; Scaccabarozzi, Diletta; Signorini, Lucia; Perego, Federica; Ilboudo, Denise P.; Ferrante, Pasquale; Delbue, Serena |
2020 |
2020-01-08 |
COMM-USE |
N |
PMC7022795 |
31936284.0 |
10.3390/microorganisms8010085 |
k4tghibp |
0.369001 |
|
Martínez_2008 |
108 |
Adhikari_2017 |
Chapter 11 Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches |
Adhikari, Nilanjan; Baidya, Sandip K.; Saha, Achintya; Jha, Tarun |
2017 |
2017-12-31 |
PMC |
N |
PMC7150231 |
|
10.1016/b978-0-12-809712-0.00011-3 |
z6v6s46n |
0.366996 |
|
Rut_W_2020, Zhou_2011 |
109 |
Salata_2019 |
Ebola Virus Entry: From Molecular Characterization to Drug Discovery |
Salata, Cristiano; Calistri, Arianna; Alvisi, Gualtiero; Celestino, Michele; Parolin, Cristina; Palù, Giorgio |
2019 |
2019-03-19 |
COMM-USE |
N |
PMC6466262 |
30893774.0 |
10.3390/v11030274 |
nfibuobt |
0.364428 |
|
|
110 |
Shannon_2020 |
Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites |
Shannon, Ashleigh; Tuyet Le, Nhung Thi; Selisko, Barbara; Eydoux, Cecilia; Alvarez, Karine; Guillemot, Jean-Claude; Decroly, Etienne; Peersen, Olve; Ferron, Francois; Canard, Bruno |
2020 |
2020-04-10 |
PMC |
Y |
|
|
10.1016/j.antiviral.2020.104793 |
rw37biop |
0.364218 |
|
|
111 |
Schandock_2017 |
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses |
Schandock, Franziska; Riber, Camilla Frich; Röcker, Annika; Müller, Janis A.; Harms, Mirja; Gajda, Paulina; Zuwala, Kaja; Andersen, Anna H. F.; Løvschall, Kaja Borup; Tolstrup, Martin; Kreppel, Florian; Münch, Jan; Zelikin, Alexander N. |
2017 |
2017-09-25 |
PMC |
N |
PMC7161897 |
28945945.0 |
10.1002/adhm.201700748 |
hb1inqy8 |
0.362736 |
|
|
112 |
Beaucourt_2014 |
Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance |
Beaucourt, Stéphanie; Vignuzzi, Marco |
2014 |
2014-10-31 |
PMC |
N |
PMC7102760 |
24846716.0 |
10.1016/j.coviro.2014.04.011 |
ubwpyt3f |
0.361311 |
|
Lee_C_2019 |
113 |
UNKNOWN_1985 |
Chapter 9 Infections caused by rubella, reoviridae, retro, Norwalk and ronaviruses |
None |
1985 |
1985-12-31 |
PMC |
N |
|
|
10.1016/s0168-7069(08)70017-x |
8f4eoeix |
0.359432 |
|
Hsieh_2010, Wu_H_2016 |
114 |
Gerold_2013 |
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C |
Gerold, Gisa; Pietschmann, Thomas |
2013 |
2013-10-04 |
PMC |
N |
PMC7089091 |
|
10.1007/s11901-013-0187-1 |
lgae22f8 |
0.358950 |
Jerome_2005, Wisskirchen_2014 |
Lin_K_2013 |
115 |
Kliger_2005 |
From genome to antivirals: SARS as a test tube |
Kliger, Yossef; Levanon, Erez Y.; Gerber, Doron |
2005 |
2005-03-01 |
PMC |
N |
PMC7128434 |
15749283.0 |
10.1016/s1359-6446(04)03320-3 |
dtaasxk1 |
0.358579 |
Martínez_2008, Jerome_2005, Wisskirchen_2014, Pizzorno_2019 |
Xiong_2020, Zhu_X_2015 |
116 |
De_Clercq_2007 |
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention |
De Clercq, Erik; Neyts, Johan |
2007 |
2007-06-30 |
PMC |
N |
PMC7112898 |
17481739.0 |
10.1016/j.tips.2007.04.005 |
7u1a198p |
0.358342 |
|
Hsieh_2010 |
117 |
Reichert_2012 |
Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections |
Reichert, Janice M. |
2012 |
2012-08-16 |
PMC |
N |
PMC7100544 |
17263584.0 |
10.2165/00063030-200721010-00001 |
yh96792l |
0.353819 |
Dove_2004, Jerome_2005 |
Flego_2013 |
118 |
Chen_2013 |
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses |
Chen, Hui-Wen; Cheng, Jenna Xiao; Liu, Ming-Tsan; King, Kevin; Peng, Ju-Yi; Zhang, Xin-Quan; Wang, Ching-Ho; Shresta, Sujan; Schooley, Robert T.; Liu, Yu-Tsueng |
2013 |
2013-09-30 |
None |
N |
PMC3787953 |
23820269.0 |
10.1016/j.antiviral.2013.06.014 |
8mf49adq |
0.353709 |
|
Lee_C_2019 |
119 |
Long_2015 |
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry |
Long, Jason; Wright, Edward; Molesti, Eleonora; Temperton, Nigel; Barclay, Wendy |
2015 |
2015-02-10 |
COMM-USE |
N |
PMC4431382 |
26069727.0 |
10.12688/f1000research.6085.2 |
57zy6unz |
0.352826 |
|
|
120 |
Ghosh_2012 |
Enhancing Protein Backbone Binding—A Fruitful Concept for Combating Drug‐Resistant HIV |
Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.; Mitsuya, Hiroaki |
2012 |
2012-01-31 |
PMC |
N |
PMC7159617 |
22290878.0 |
10.1002/anie.201102762 |
z0hxrrhy |
0.350070 |
|
|
121 |
Wu_X_2017 |
Progress of small molecular inhibitors in the development of anti-influenza virus agents |
Wu, Xiaoai; Wu, Xiuli; Sun, Qizheng; Zhang, Chunhui; Yang, Shengyong; Li, Lin; Jia, Zhiyun |
2017 |
2017-02-08 |
NONCOMM |
N |
PMC5381247 |
28382157.0 |
10.7150/thno.17071 |
diemj28t |
0.346112 |
|
De_Clercq_2007, Vardanyan_2016 |
122 |
Pruijssers_2019 |
Nucleoside analogues for the treatment of coronavirus infections |
Pruijssers, Andrea J; Denison, Mark R |
2019 |
2019-04-30 |
PMC |
N |
PMC7102703 |
31125806.0 |
10.1016/j.coviro.2019.04.002 |
sgedojwh |
0.344457 |
Li_C_2019, Martínez_2008 |
Adedeji_2014 |
123 |
Savarino_2006 |
Potential therapies for coronaviruses |
Savarino, Andrea; Buonavoglia, Canio; Norelli, Sandro; Trani, Livia Di; Cassone, Antonio |
2006 |
2006-08-31 |
PMC |
N |
PMC7103690 |
|
10.1517/13543776.16.9.1269 |
z739ifu5 |
0.343203 |
|
Lee_C_2019, Al‐Bari_2017 |
124 |
Al‐Bari_2017 |
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases |
Al‐Bari, Md. Abdul Alim |
2017 |
2017-01-23 |
COMM-USE |
N |
PMC5461643 |
28596841.0 |
10.1002/prp2.293 |
201jppkd |
0.343097 |
|
Jung_2019, Zhu_X_2015 |
125 |
Xiao_2018 |
Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives |
Xiao, Sulong; Tian, Zhenyu; Wang, Yufei; Si, Longlong; Zhang, Lihe; Zhou, Demin |
2018 |
2018-01-19 |
PMC |
N |
PMC7168445 |
29350407.0 |
10.1002/med.21484 |
8sh91ztl |
0.339407 |
Sousa_2016, Fernández‐Oliva_2019 |
|
126 |
Tomar_2020 |
Chapter 19 Advances in structure-assisted antiviral discovery for animal viral diseases |
Tomar, Shailly; Mahajan, Supreeti; Kumar, Ravi |
2020 |
2020-12-31 |
PMC |
N |
PMC7149589 |
|
10.1016/b978-0-12-816352-8.00019-9 |
mog52dn8 |
0.335903 |
|
Lee_C_2019, Chang_2019, Zhu_X_2015 |
127 |
Mercorelli_2018 |
Drug Repurposing for Viral Infectious Diseases: How Far Are We? |
Mercorelli, Beatrice; Palù, Giorgio; Loregian, Arianna |
2018 |
2018-10-31 |
None |
N |
PMC7126639 |
29759926.0 |
10.1016/j.tim.2018.04.004 |
7jhjlxtf |
0.334996 |
Dove_2004, Li_C_2019, Pizzorno_2019, Martínez_2008 |
Pizzorno_2019, Martínez_2008, Schor_2018, D’Alessandro_2020 |
128 |
Kilianski_2014 |
Cell-based antiviral screening against coronaviruses: Developing virus-specific and broad-spectrum inhibitors |
Kilianski, Andy; Baker, Susan C. |
2014 |
2014-01-31 |
None |
N |
PMC3931262 |
24269477.0 |
10.1016/j.antiviral.2013.11.004 |
y3zrt52j |
0.334624 |
|
Xiong_2020, Adedeji_2014 |
129 |
Kuo_R_2013 |
Strategies to develop antivirals against enterovirus 71 |
Kuo, Rei-Lin; Shih, Shin-Ru |
2013 |
2013-01-22 |
COMM-USE |
N |
PMC3614426 |
23339605.0 |
10.1186/1743-422x-10-28 |
nj4p03cr |
0.334584 |
Jerome_2005 |
Hsieh_2010 |
130 |
Kaufmann_2017 |
Host-directed therapies for bacterial and viral infections |
Kaufmann, Stefan H. E.; Dorhoi, Anca; Hotchkiss, Richard S.; Bartenschlager, Ralf |
2017 |
2017-09-22 |
None |
N |
PMC7097079 |
28935918.0 |
10.1038/nrd.2017.162 |
sf14vnii |
0.331747 |
Wisskirchen_2014 |
Ahmed_2019, Müller_2009 |
131 |
Ahmed_2019 |
Human Antimicrobial Peptides as Therapeutics for Viral Infections |
Ahmed, Aslaa; Siman-Tov, Gavriella; Hall, Grant; Bhalla, Nishank; Narayanan, Aarthi |
2019 |
2019-08-01 |
COMM-USE |
N |
PMC6722670 |
31374901.0 |
10.3390/v11080704 |
ylyof9hb |
0.331400 |
|
Lee_C_2019, Gwyer_Findlay_2013, Kaufmann_2017 |
132 |
Bray_2010 |
Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes |
Bray, Mike; Di Mascio, Michele; de Kok-Mercado, Fabian; Mollura, Daniel J.; Jagoda, Elaine |
2010 |
2010-11-30 |
PMC |
N |
PMC7125728 |
20709111.0 |
10.1016/j.antiviral.2010.08.005 |
hqijd268 |
0.329691 |
|
Vardanyan_2016 |
133 |
Prasanth_2020 |
Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses |
K. Reddisiva Prasanth; Minato Hirano; W. Samuel Fagg; Eileen T. McAnarney; Chao Shan; Xuping Xie; Adam Hage; Colette A. Pietzsch; Alexander Bukreyev; Ricardo Rajsbaum; Pei-Yong Shi; Mark T. Bedford; Shelton S. Bradrick; Vineet Menachery; Mariano A. Garcia-Blanco |
2020 |
2020-03-27 |
BioRxiv |
Y |
|
|
10.1101/2020.03.24.005900 |
a0xfb9l4 |
0.321157 |
|
|
134 |
Chang_2019 |
Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors |
Chang, Kyeong-Ok; Kim, Yunjeong; Lovell, Scott; Rathnayake, Athri D.; Groutas, William C. |
2019 |
2019-02-25 |
COMM-USE |
N |
PMC6410195 |
30823509.0 |
10.3390/v11020197 |
r11lq8dd |
0.318467 |
|
Lee_C_2019 |
135 |
Hsieh_2016 |
The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy |
Hsieh, I-Ni; Hartshorn, Kevan L. |
2016 |
2016-09-06 |
COMM-USE |
N |
PMC5039506 |
27608030.0 |
10.3390/ph9030053 |
3f60q9wc |
0.316680 |
|
Ahmed_2019, Gwyer_Findlay_2013, Lee_C_2019 |
136 |
Berry_2014 |
Passive Broad-Spectrum Influenza Immunoprophylaxis |
Berry, Cassandra M.; Penhale, William J.; Sangster, Mark Y. |
2014 |
2014-09-22 |
COMM-USE |
N |
PMC4190013 |
25328697.0 |
10.1155/2014/267594 |
e0sywsoi |
0.316529 |
|
Hsieh_2010 |
137 |
Meanwell_2003 |
Chapter 22. Non-HIV antiviral agents |
Meanwell, Nicholas A.; Serrano-Wu, Michael H.; Snyder, Lawrence B. |
2003 |
2003-12-31 |
PMC |
N |
|
|
10.1016/s0065-7743(03)38023-6 |
d4qcckh1 |
0.316421 |
|
Vardanyan_2016, Paintsil_2009 |
138 |
Liu_A_2012 |
Antiviral Properties of Phytochemicals |
Liu, Ai-Lin; Du, Guan-Hua |
2012 |
2012-02-18 |
PMC |
N |
PMC7120890 |
|
10.1007/978-94-007-3926-0_3 |
vuj5kjl5 |
0.314207 |
Pastuch-Gawołek_2019, Li_C_2019 |
Chattopadhyay_2009, Bekut_2018 |
139 |
Amanat_2020 |
SARS-CoV-2 Vaccines: Status Report |
Amanat, Fatima; Krammer, Florian |
2020 |
2020-04-06 |
PMC |
Y |
|
|
10.1016/j.immuni.2020.03.007 |
m5ho8jqp |
0.310378 |
|
|
140 |
Yasmin_2020 |
Chapter 7 Herbal extracts as antiviral agents |
Yasmin, A.R.; Chia, S.L.; Looi, Q.H.; Omar, A.R.; Noordin, M.M.; Ideris, A. |
2020 |
2020-12-31 |
PMC |
N |
PMC7150227 |
|
10.1016/b978-0-12-814700-9.00007-8 |
eub1ofpm |
0.309492 |
Lin_L_2014 |
Chattopadhyay_2015, Bekut_2018 |
141 |
Galdiero_2011 |
Silver Nanoparticles as Potential Antiviral Agents |
Galdiero, Stefania; Falanga, Annarita; Vitiello, Mariateresa; Cantisani, Marco; Marra, Veronica; Galdiero, Massimiliano |
2011 |
2011-10-24 |
COMM-USE |
N |
PMC6264685 |
22024958.0 |
10.3390/molecules16108894 |
962vynwk |
0.308896 |
Jerome_2005 |
Lee_C_2019, Al‐Bari_2017, Gwyer_Findlay_2013 |
142 |
Li_Y_2020 |
Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening |
Yan Li; Jinyong Zhang; Ning Wang; Haibo Li; Yun Shi; Gang Guo; Kaiyun Liu; Hao Zeng; Quanming Zou |
2020 |
2020-01-29 |
BioRxiv |
Y |
|
|
10.1101/2020.01.28.922922 |
iu2ziccm |
0.304489 |
Shaw_2011, Jerome_2005 |
Zhu_X_2015, Lee_C_2019 |
143 |
Arbuthnot_2015 |
Chapter 12 Antiviral Gene Therapy Summary and Perspectives |
Arbuthnot, Patrick |
2015 |
2015-12-31 |
PMC |
N |
PMC7149688 |
|
10.1016/b978-0-12-410518-8.00012-0 |
0552df7s |
0.304432 |
|
Müller_2009 |
144 |
Sample_2013 |
A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses |
Sample, Christopher J.; Hudak, Kathryn E.; Barefoot, Brice E.; Koci, Matthew D.; Wanyonyi, Moses S.; Abraham, Soman; Staats, Herman F.; Ramsburg, Elizabeth A. |
2013 |
2013-10-01 |
PMC |
N |
PMC3899704 |
23891650.0 |
10.1016/j.peptides.2013.07.014 |
aazy94cf |
0.303587 |
|
Lee_C_2019, Zhu_X_2015 |
145 |
Pastuch-Gawołek_2019 |
Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
Pastuch-Gawołek, Gabriela; Gillner, Danuta; Król, Ewelina; Walczak, Krzysztof; Wandzik, Ilona |
2019 |
2019-12-15 |
PMC |
N |
|
31634460.0 |
10.1016/j.ejphar.2019.172747 |
9oj6m3df |
0.303361 |
Li_C_2019, Beigel_2010 |
|